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ABSTRACT
The relations between minor life events, compliance, urine
free cortisol, and blood glucose in 40 adults with
insulin-dependent diabetes mellitus (IDDM) was examined.
Specifically, this study explored whether naturallyoccurring minor stressful events had disruptive effects on
metabolic control through: a) an arousal mechanism
mediated by cortisol, b) disruption of the individual's
adherence to prescribed treatment, c) a combination of
arousal and disruption of compliance, or d) a third,
unspecified mechanism.

Stress did not influence metabolic

control, either independently or via a stress-compliance
or stress-arousal mechanism although stress was related to
cortisol activity.

Neither the direct effects of

cortisol nor a cortisol by stress interaction successfully
predicted metabolic control.

Moreover, stress was

unrelated to diet or exercise compliance and no relation
between diet or exercise compliance and metabolic control
was found.

Only insulin compliance was found to influence

metabolic control, although the effects of insulin
compliance were independent of a stress-compliance
relation.

Implications of the results and directions for

further research are discussed.

INTRODUCTION

Investigation of psychological factors in diabetes
mellitus (DM) has a long history (see Johnson, 1980 for a
review).

Although the notion of a "diabetic personality"

is no longer tenable (Dunn & Turtle, 1981), considerable
research continues on psychological variables influencing
the disorder's course.

In particular, researchers have

shown stress may influence metabolic stability in
individuals having the disease (see Goetsch, 1989 for a
review).

In addition, those factors moderating the

influence of stress on the disease have been important.
Adults with DM provide an excellent population for
investigating the effects of stress on the disorder.

In

addition to the stringent requirements of their treatment
regimen, insulin-dependent DM patients have a higher
frequency of hospital admissions and are more likely to
experience poor metabolic control than do their non
insulin dependent cohorts (Davis, Hess, Van Harrison, &
Hiss, 1987).

Poor metabolic control may increase the

likelihood of developing complications associated with the
disorder.

Adults with DM are, therefore, by virtue of the

length and nature of their illness, a population at risk
for severe complications of their disease.

Determining

the extent to which minor stress may contribute to the
increased risk is an area needing research.
1

The purpose of this investigation was to examine the
two primary hypothetical mechanisms regarding the effects
of stress on metabolic control in DM.

Both the direct

effects via a sympathetically-mediated arousal mechanism
and indirect effects via disruption of compliance
behaviors were explored.

Specifically, the relations

between minor life events, compliance behaviors, urine
free cortisol, and blood glucose in young adults with
insulin-dependent diabetes mellitus (IDDM) were
investigated.
In the ensuing literature review, an overview of DM
will be provided, including the pathophysiology and
treatment of the disorder followed by current etiological
theories.

In addition, a brief introduction to the

concept of stress and its relation to illness will be
included.

Finally, a review of available literature

regarding stress-arousal and stress-compliance hypotheses
and their relation to metabolic stability in IDDM will be
presented.
Definition and Impact of the Disorder
Diabetes mellitus is a group of complex disorders of
carbohydrate metabolism associated with compromised
insulin activity or production.

The cardinal symptom of

DM is hyperglycemia, however, polyuria, polydipsia,
polyphagia, fatigue, weight loss, and blurred vision also
characterize DM (Olefsky, 1988).

In addition, a variety

of microvascular and macrovascular complications are
associated with the disorder.

Microvascular complications

include thickening of the capillary basilar membranes,
retinopathy, and nephropathy, while accelerated
atherosclerotic development and peripheral vascular
disease are common macrovascular complications.

Other

frequent problems include peripheral neuropathy,
complications of pregnancy, and increased risk of
infection (Davidson, 1981; Kahn, 1985).
The U.S. Department of Health and Human Services
(USDHHS, 1985) estimates as many as 10 million Americans
currently have DM.

DM is the 10th leading cause of death

in the United States (Turk & Speers, 1983) and the leading
cause of new blindness (Davidson, 1981).

Risk of stroke

and myocardial infarction is increased 2-fold in
individuals with DM, while risk of renal failure is 17
times greater (Cahill, 1985? Davidson, 1981).

Individuals

with DM also are at significantly increased risk of
developing coronary artery disease.

Moreover, incidence

of peripheral vascular disease is increased 50 times over
non-diabetics (Cahill, 1985) contributing to the high rate
of amputations in this population.
DM also represents a significant economic burden.

In

1980, economic costs of DM were estimated to be as high as
$9.7 billion including costs of morbidity and mortality
(Krall, Entmacher, & Drury, 1985).

Direct costs of

medically related services were approximately $4.8
billion, including $2.2 billion for medical care, $1.24
billion for nursing home care, $840 million for patient
visits to physicians, and $380 million for medication
(Krall et al., 1985).
The World Health Organization (WHO, 1980) has
proposed three classification categories of DM including
Type I DM, or insulin-dependent diabetes mellitus (IDDM),
Type II, or noninsulin-dependent diabetes mellitus
(NIDDM), and DM associated with specific medical
conditions (e.g., pancreatic disease, genetic syndromes,
drug-induced conditions).

The remainder of this

discussion will focus on Type I DM, or IDDM.
Pathophysiology of IDDM
Insulin, an anabolic hormone secreted by pancreatic
beta cells, regulates storage and use of the body's energy
sources.

Three primary insulin-sensitive tissues are

influenced by its action: liver, muscle, and adipose
tissue.

In the liver, insulin stimulates the storage of

glucose as glycogen or fat.

Moreover, the presence of

active insulin controls glycogenolysis (the breakdown of
glycogen into glucose) in a fasting state.

In muscle and

adipose tissue, insulin serves to increase cell
permeability to glucose providing cells with a readily
available energy source.

Insulin also facilitates fat

synthesis and inhibits breakdown of previously stored

fats.

Finally, insulin influences protein metabolism by

facilitating protein synthesis and inhibiting breakdown of
stored protein in tissues (Davidson, 1981).
Under normal conditions, insulin secretion increases
after one eats in response to the carbohydrate and protein
content of a meal (Davidson, 1981).

Increased circulating

levels of insulin stimulate storage of glucose and fat as
energy reserves in insulin-sensitive tissues.
fasts, insulin levels decline.

While one

The relative lack of

insulin during a fast (i.e., between meals and at night)
facilitates release of stored glucagon and fatty acids as
fuel sources (Cahill, 1985).

Any disruption of the

balance of this process serves to alter significantly the
body's metabolism of carbohydrates, fats, and proteins.
In Type I DM, beta cells of the pancreas fail to
produce insulin, resulting in an absolute deficiency of
endogenous insulin.

Therefore, while fasting one's

insulin deficiency provides a continuous signal to
insulin-sensitive tissues to release stored fuels.
Fasting blood glucose levels of individuals with Type I DM
are, therefore, significantly elevated over normals.

A

further postprandial elevation of blood glucose also
occurs in individuals with IDDM.

Consequently,

individuals with IDDM experience both fasting and
postprandial hyperglycemia. Hyperglycemia is currently the

most commonly used basis for diagnosis of DM (Davidson,
1981).
Left untreated, hyperglycemia further deteriorates in
the absence of insulin's inhibitory effects on
glyconeolysis and leads to water and electrolyte depletion
(Davidson, 1981).

Changes in protein metabolism caused by

a lack of insulin results in the synthesis of additional
glucose from amino acids as well as water and electrolyte
imbalances.
Additional detrimental effects may be caused by
changes in fat metabolism.

Lack of available insulin

leads to accelerated lypolysis (i.e., breakdown of
triglycerides) and subsequent increases in glycerol and
free fatty acids (FFA) in blood.

Glycerol contributes to

further release of glucose by the liver further
complicating the hyperglycemic state.

Moreover, FFA

release leads to ketogenesis (i.e., the development of
ketone bodies).

Overproduction of ketone bodies can

exceed the body's ability to neutralize acid effects and
acidosis may ensue (Davidson, 1981).
The constellation of acidosis, ketonuria (i.e.,
ketone bodies in the urine), dehydration, and electrolyte
depletion is known as diabetic ketoacidosis (DKA) and is
life-threatening.

DKA may be the first clinical

indication of IDDM (Olefsky, 1988) and prior to discovery
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of insulin was the leading cause of death in persons with
IDDM (Davidson, 1981).
Management of IDDM
Maintenance of a normoglycemia is the primary goal of
diabetes treatment (Olefsky, 1988).

Available evidence

suggests prolonged hyperglycemic conditions may
significantly contribute to development of microvascular
complications and increase the likelihood of later kidney
and eye disease (Cahill, Etzwiler, & Freinkel, 1976;
Olefsky, 1988; Zimmerman, 1989).

Hypoglycemic states,

conversely, can quickly result in permanent damage to the
central nervous system (Olefsky, 1988).
Presently, the principal means of attaining
normoglycemia is through use of exogenous insulin
injections.

Most IDDM patients must administer at least

two injections daily of some combination of short-,
intermediate-, or long-acting insulin in an attempt to
approximate the action of endogenous insulin.

Glucose

levels also must be monitored by the patient several times
daily to assess glycemic control.

Unfortunately,

exogenous insulin injections are only partially successful
in achieving normoglycemia (Cahill et al., 1976).
Insulin-infusion pumps, an alternative to selfadministration of injections, are a more recent
development in treatment of IDDM.

Pumps provide insulin

to the individual 24 hours a day and provide a potential

means to improve glycemic control.

However, nocturnal

hypoglycemia is a serious potential side effect of
infusion pump use (Olefsky, 1988).

In addition, pumps

present a more visible indicator of illness and may
require even more lifestyle changes than insulininjections (Olefsky, 1988).

Regardless of the method of

insulin therapy used (i.e., injection or pump), a great
deal of responsibility for management of the disorder
rests with the patient (Olefsky, 1988).
In addition to insulin therapy, IDDM patients must
adhere to stringent diets.

The number of calories

ingested and the source of the calories

(i.e., fats,

carbohydrates, etc.) must be closely monitored.

A low

level of fats in the diet and reduced ingestion of sugars
are minimal requirements of a diabetic diet.

Timing of

meals is also important because caloric intake must be
adjusted to correspond to available insulin activity.
Frequent small meals are, therefore, generally prescribed
to avoid significant post-prandial metabolic changes.
A third area of IDDM treatment involves exercise.

A

moderate physical exercise regimen is often prescribed by
the physician as part of a total treatment program.
Exercise may improve glucose utilization and decrease
peripheral resistance to insulin (Ekoe, 1988).

Excessive

exercise or exercise in the presence of insufficient
insulin, however, may result in hypoglycemia (Horton,

1988).

Nonetheless, exercise is a frequent component of

diabetes management.
Finally, patient education is an important component
of diabetes management.

The complex nature of the

disorder and the demands placed on the patient require a
high level of understanding of the disease.

A recent

meta-analysis of educational interventions reported
patient education was a significant factor in positive
patient outcome (Brown, 1988).
Etiology of IDDM
Although damage to the pancreatic beta cells in
patients with DM was noted at the turn of the century
(Cahill, 1985), to date the etiology of the disorder has
eluded medical researchers.

Nonetheless, scientists agree

the disease appears to run in families and is frequently
associated with infectious processes and abnormal
immunological functioning.

These findings have led

researchers to suggest DM is a complex phenomenon subject
to multiple influences (Soeldner, 1982).

A brief

literature review of the three primary areas involved in
the etiology of IDDM follows; namely genetic, viral, and
autoimmune contributions.

The role of psychological

factors in the etiology and course of the disease also
will be discussed.
Genetic Influences.

Three primary lines of evidence

support a genetic role in the etiology of DM.

Data from
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twin, family, and histocompatibility antigen studies
support a genetic contribution.
from conclusive.

However, the data are far

Using more than 100 monozygotic twin

pairs, Pyke and Nelson (1976) found 50% concordance in
twins diagnosed with DM before age 40.

Based on age at

diagnosis, these data appear related to individuals with
IDDM.

However, in twins whose diagnoses were made after

age 40 (suggesting a diagnosis of NIDDM), concordance
approached 100%.

Others have reported similar findings

(Gottlieb & Root, 1968).

A strong genetic component in

NIDDM is suggested, but data are less conclusive regarding
an etiological role of heredity in Type I DM.
No identifiable pattern of inheritance has been
identified in patients with IDDM (Craighead, 1978)
although it is agreed the syndrome is not autosomal
dominant (Olefsky, 1988).

Reports based on family studies

reveal a fairly low degree of direct transmission from
affected parents to offspring.

Risk to offsprings of

diabetic parents is estimated to be 2 to 5% compared to
0.2 to 0.3% risk in the general population.

For children

with IDDM, sibling risk increases to 5 to 10% (Olefsky,
1988).

Significantly increased risk is accrued, however,

if siblings are human leukocyte antigen (HLA) identical to
the affected sibling (Olefsky, 1988).
Although no specific genetic marker for IDDM has been
identified, researchers have expressed considerable
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interest in the increased incidence of IDDM associated
with certain HLA antigens.

The presence of the HLAs

does not directly cause IDDM; rather specific loci of the
major histocompatibility complex encoded on chromosome 6
appear related to increased risk (Olefsky, 1988).

HLAs

may offer a means of identifying those individuals most
vulnerable to IDDM and provide clues to the existence of a
••diabetogenic" gene (Olefsky, 1988) .
The preponderance of evidence from genetic studies
suggests IDDM is influenced by genetic factors.

Yet,

available data also indicate an equally strong influence
of nongenetic variables.

Olefsky (1988) suggests

determination of the precise contribution of heredity is
difficult for four primary reasons: 1) no specific marker
has been identified, 2) the degree of heterogeneity both
within and between types of DM (i.e., IDDM and NIDDM), 3)
the interaction between a "diabetogenic" gene, other
genetic factors, and environmental factors, and 4) low
rates of transmission of the disorder from generation to
generation.

At present, the majority of investigators

believe genetic factors are diathetic, requiring other
influences to result in expression of the illness
(Craighead, 1978; Olefsky, 1988) .
Viral Influences.

A second area of interest in the

etiology of IDDM involves the role of viral agents.
his review Olefsky (1988) outlined several lines of

In

evidence for a viral component in the onset of IDDM.
First, incidence of IDDM has been reported to vary on a
seasonal basis.

A number of authors report increased

onset of DM during the late summer to early autumn or
winter months (e.g., MacMillan, Kotoyan, Zeidner, &
Hafezi, 1977) corresponding to the presence of increased
viral infections during these times.

Second, a history of

viral illness is frequently found to precede diagnosis of
IDDM, particularly mumps (Sultz, Hart, Zielezny, &
Schlesinger, 1975) and Coxsackie B virus (Gamble, Kinsley,
FitzGerald, Bolton, & Taylor, 1969).

Third, an increase

in viral titers is often found in patients newly diagnosed
with IDDM at or near the beginning of their illness.
A fourth line of evidence to support a viral role in
the onset of IDDM involves the use of animal studies.
Injections of "diabetogenic" viruses (e.g., Coxsackie B,
encephalomyocarditis) can led to onset of IDDM in rodents.
Moreover, the likelihood of developing IDDM after viral
innoculation can be manipulated by varying genetic
susceptibility to the disease.

This evidence supports a

predisposing role of heredity in IDDM that is further
aggravated by the presence of physiological stressors
(i.e., viral infection).

Finally, "diabetogenic" viruses

introduced to beta cells in culture medium have been shown
to cause cell lysis and necrosis (e.g., Prince, Jensen,
Billup, & Notkins, 1978).

These findings are particularly
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indicative of a viral component to IDDM suggesting a
direct effect of viral activity on pancreatic beta cell
integrity.
Autoimmune Influences.

A final area of concern in

the etiology of IDDM involves autoimmune reactions.

An

automimmune process is believed to affect beta cells
leading to their destruction (Kahn, 1985).

Several lines

of evidence support an autoimmune reaction in IDDM.
First, IDDM is frequently associated with other endocrine
disorders of autoimmune origin (Kahn, 1985).

In

particular, disorders of the adrenal and thyroid gland
often coexist with IDDM (Kozak & Cooppan, 1985).

Because

autoimmune disorders tend to occur more frequently in
families of affected individuals, a genetic predisposition
to develop autoimmune diseases may be involved (Kaldany,
Busick, & Eisenbarth, 1985).
Second, a number of studies indicate a high level of
islet-cell antibodies (ICA) in patients with IDDM (see
Kaldany et al., 1985 for a review).

Combined data from

several studies indicate 29.2% of patients with IDDM had
ICAs as compared to 1.3% of nondiabetic persons (Kaldany
et al., 1985).

Elevated levels of ICA are most commonly

reported in recently diagnosed individuals, although some
patients maintain high ICA titers for a number of years
(Kaldany et al., 1985).

While these results are far from

conclusive and data exist to suggest the presence of ICAs
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alone are insufficient to account for the disorder (cf.,
(Olefsky, 1988, Kahn, 1985), increased levels of ICAs at
or about the time of diagnosis in IDDM nonetheless
suggests involvement of an autoimmune process.

Finally,

immunosuppressive treatment has been shown to prevent
development of IDDM in genetically susceptible rats
(Laupacis et al., 1983; Like, Anthony, Guberski,

&

Rossini, 1983).
In summary, similar to the potential viral influences
in the etiology of IDDM, autoimmunity appears to play a
role in the genesis of the disease.

At present, however,

the mechanism initiating an autoimmune response is unknown
(Kahn, 1985).

The most plausible explanation of the

etiology of IDDM, based on current data, is that an immune
response is initiated in response to environmental factors
(e.g., viruses or toxins).

The autoimmune response,

modulated by genetic variables, then results in beta cell
destruction.

That is, the multiple effects of genetic,

viral, and autoimmune influences culminate in IDDM.
Influence of Psychological Factors.

Throughout

history, psychological factors have been believed to have
a role in the etiology of DM.

Thomas Willis, in the 17th

century, believed DM was caused by prolonged sorrow
(Johnson, 1980).

More recently, Menninger (1935)

suggested anxiety and depression were characteristic of
the 'diabetic personality'.

These theories grew largely
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from the psychoanalytic perspective suggesting specific
personality traits caused or led to an exacerbation of the
disease via displacement of psychological conflicts
(Daniels, 1939).

Individuals with DM were variously

believed to be less alert, more apathetic, more
hypochondriacal, and more likely to become depressed than
were non-diabetic persons (Menninger, 1935).
In a seminal review article by Dunn and Turtle
(1981) , the concept of a specific diabetic personality
with etiological implications for the disorder was
seriously challenged.

Investigations of specific traits

etiologically linked to DM have been methodologically
flawed (Dunn & Turtle, 1981) and have little empirical
support (Dunn & Turtle, 1981; Surwit, Feinglos, & Scovern,
1983; Turk & Speers, 1983).

No consistent traits have

been identified across individuals with DM (Surwit et al.,
1983).

Thus, theories of personality factors as

contributors to the etiology of the disease are no longer
accepted.
Psychological factors, however, continue to be an
important area of research.

Over the course of the

disorder researchers have found psychologically meaningful
events (i.e., stress) may influence metabolic control of
individuals having the disease.

Investigation of the role

of stress in DM grew largely from clinical observations of
the frequency of stressful occurrences associated with

onset of diabetic crisis.

Decompensation of diabetic

control (i.e., DKA) may be precipitated by emotional or
environmental stress (Olefsky, 1988).

Nabarro (1965)

found that approximately 14% of severe DKA cases were
preceded by environmental stress.

Similarly, Cohen,

Vance, Runyan, and Hurwitz (1960) reported stress related
to onset of DKA in approximately 15% of their sample.
These findings have resulted in a large body of literature
on the effects of stress on metabolic control.

In

addition, those factors that may moderate or mediate the
influence of stress on the disease have been an important
area of investigation.

STRESS AND ILLNESS
Before proceeding to a review of the pertinent
literature involving stress effects on metabolic control
in IDDM, a discussion of the concept of stress will be
provided.

In addition, two principal means of

investigating the stress-disorder relation, that is,
physiological changes associated with stress and the
influence of life events on IDDM will be provided.
Stress, as formulated by Selye (1956), is manifested
by a pattern of physiological responses (i.e., the General
Adaptation Syndrome) influencing the likelihood of
illness.

According to Selye*s model, after exposure to

demands the body responds via biochemical activity.

For

Selye, these biochemical changes defined stress.
Continued stress leads to attempts to regain homeostasis
and counteract the physiological effects of environmental
demands.

Prolonged exposure to stressors, however,

depletes the organism's ability to maintain a homeostatic
state effectively.

Exhaustion quickly ensues resulting in

breakdown of the body's defensive systems, subsequent
tissue damage, and perhaps death.

Selye's model of stress

in the pathogenesis of illness, therefore, involves
depletion of homeostatic adaptive mechanisms secondary to
exposure to stressors.
Selye's model provided the first systematic
theoretical notions of potential changes in physiological
17
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functioning resulting from stress.

Although Selye's work

served as the impetus for much of the later research
involving stress and illness, his theory has not stood
without criticism (see Hamberger & Lohr, 1984 for a
review).

Nonetheless, the physiological changes

accompanying the stress response proposed by Selye served
as an important model for understanding the physiological
substrates of stress.
Researchers now believe three primary biochemical
pathways are involved in the human stress response: 1) the
neural, 2) neuroendocrine, and 3) endocrine axes (Everly,
1989).

The body's earliest response to stressors involves

increased autonomic activity.

As a result of innervation

of neural pathways in the spinal cord and sympathetic
ganglia, norepinephrine (NE) is released by sympathetic
neurons, causing generalized arousal in target end organs.
Activity of the neuroendocrine axis involves release of
the adrenal medullary catecholamines, NE and epinephrine
and mimics the effects of sympathetically-mediated release
of NE (Everly, 1989).
The final phase of the stress response involves
activity of the endocrine system.

Activity of the adreno

cortical axis is a particularly important aspect of this
response.

Pituitary secretion of adrenocorticotropic

hormone (ACTH) leads to stimulation of the adrenal cortex.
In response to ACTH, the adrenal cortex secretes
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glucocorticoids and mineralocorticoids.

The primary

glucocorticoids, cortisol and corticosterone, have a
number of systemic effects including increased glucose
production, increased production of urea, increased
release of free fatty acids, and suppression of immune
responses and appetite (Everly, 1989).

The

mineralocorticoids, aldosterone and deoxycorticosterone
are important in regulation of electrolytes and serve to
increase blood pressure.
Much of stress research has focused on the activity
of cortisol, the principal glucocorticoid secreted by the
adrenal cortex.

Researchers have reported significantly

increased cortisol levels associated with a variety of
laboratory stressors including: venipuncture stress
(Hubert, Moller, & Nieschlag, 1989), caffeine
administration, reaction time tasks (Lovallo et al.,
1989), mental arithmetic (Pomerleau & Pomerleau, 1990) ,
and examination stress (Meyerhoff, Oleshansky, & Mougey,
1988).

Daily minor stress also has been reported to

influence cortisol levels.

Brantley, Dietz, McKnight,

Jones, and Tulley (1988a) reported a positive relation
between daily fluctuations in minor stressful events and
cortisol in medical personnel.
In summary, Selye's (1956) conceptualization of
stress as a series of specific physiological responses has
led to investigation and further understanding of the
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autonomic and endocrine activity associated with
environmental stressors.

Research indicates that

laboratory and relatively minor life events can influence
the physiological parameters underlying human stress.
Drawing from Cannon's (1935) early work, another
tradition evolved to explore the effects of stress on
health.

Cannon's (1935) investigations focused on the

stimulus properties of physical or emotional stress in
disrupting internal homeostatic mechanisms.

In contrast

to Selye, Cannon viewed stress as the stimulus leading to
physiological changes.

The shift in focus from the

response of the organism as "stress" to the stimulus as
"stress" led to the development of interest in the role of
life events as potential mediators of the stress-illness
relation.

A great deal of research has focused on the

role of life events in the cause or exacerbation of
illness.

The occurrence of life events now is believed to

be a risk factor for adverse health outcome (Elliot &
Eisdorfer, 1982).
Much of the early research on life events as a means
of investigating the stress-disorder relation developed
from the work of Holmes and Rahe (1967) on adjustment to
major life events.

Major life events are frequently

associated with significant life change and include, for
example, marriage, birth of a child, or death of a loved
one.

Using the Schedule of Recent Events (SRE) to assess
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the occurrence of major life events, respondents indicate
which of 43 major life events occurred during the past
year.

A number of studies have reported positive

relations between the occurrence of major life events and
both physical and psychological symptoms (see Dohrenwend &
Dohrenwend, 1978, 1981; Rabkin & Streuning, 1976 for
reviews).

The adjustment required by these events are

proposed to increase significantly the likelihood of
developing a variety of physical disorders (Rahe & Arthur,
1978).
Although use of the SRE or modifications of the scale
dominated behavioral medicine research on stress during
the 1970s (Kanner, Coyne, Schaefer, & Lazarus, 1981), the
research has not been without criticism (see Dohrenwend &
Dohrenwend, 1978 for a review).

Criticisms of the life-

events approach have ranged from psychometric issues
(e.g., Schroeder & Costa, 1984) to effect size (e.g.,
Rabkin & Streuning, 1976).

Empirical support for the

effect of major life events on illness, for example, has
traditionally been quite modest (Rabkin & Streuning,
1976).
In addition, the SRE does not allow the respondent to
indicate whether the change associated with the life event
is positive or negative in direction.

Several authors

reported no relation between change associated with
positive major life events (e.g., birth of a child) and

later adaptation (e.g., Ross & Minowsky, 1979; Vinokur &
Selzer, 1975).

In response to the criticisms of the SRE,

Sarason, Johnson, and Siegel (1978) attempted to improve
assessment of major life events through development of the
Life Experiences Survey (LES).

The LES is more carefully

worded than the SRE and allows respondents to indicate
whether the event was positive or negative.

In addition,

the LES provides subjects with the opportunity to indicate
the subjective impact of the event on a Likert-type scale.
More recently, investigators interested in the
stress-disorder relation have focused attention on effects
of daily minor stressors or "hassles"

(Brantley, Waggoner,

Jones, & Rappaport, 1987; DeLongis, Coyne, Dakof, Folkman,
& Lazarus, 1982; Kanner et al., 1981, Monroe,

1983).

Minor stressors include such things as getting stuck in
traffic, performing poorly on a task, or bad weather.
Compared to major life events, minor stressors more likely
occur on a daily basis and generally impact the individual
less (Brantley & Jones, 1989).

Investigations of minor

stress may offer information on the temporal relation
between symptom onset and exacerbation not apparent when
using more global, retrospective measures of major life
events.

In addition, minor stress contributes information

independently of what can be attributed to major life
events in predicting physical symptoms (DeLongis et al.,
1982) .
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Stress and IDDM
Two primary hypotheses regarding effects of stress on
IDDM have been delineated.

First, stress may directly

influence metabolism in IDDM via action of the
counterregulatory or "stress" hormones, suggesting that
stress' effects on metabolism are mediated by arousal, or
activation of the sympathetic branch of the autonomic
nervous system.

In response to sympathetic arousal,

release of hormones associated with the stress response
(e.g., ACTH, growth hormone, corticosteroids, NE, and
epinephrine) result in reduced plasma insulin in normal
individuals.

Consequently, levels of blood glucose and

free fatty acids (FFA) are increased (Lustman, Carney, &
Amado, 1981; Tarnow & Silverman, 1981-82) resulting in
mobilization of energy sources for use in a "fight or
flight" response.

In individuals with DM, metabolic

changes associated with stress further compromise
metabolic stability and lead to diabetic crises.
A second theory concerning the effects of stress on
IDDM involves the indirect effects of stress on compliance
to diabetic regimens.

Accordingly, behavioral or

emotional disruption resulting from the presence of
stressors interferes with effective patient self-care.
Stress adversely influences the course of DM through its
effects on diet, insulin injections, glucose monitoring,
or other aspects of a diabetic regimen.
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Maintenance of normoglycemia requires adherence to a
complex set of demands.

IDDM patients must perform

insulin injections, maintain dietary restrictions, and
monitor blood glucose.

Moreover, these behaviors must be

performed in a temporally prescribed manner numerous times
during the day (Glasgow, McCaul, & Schafer, 1986).

As a

result, adherence to diabetic regimens is poor typically
(Fisher, Delameter, Bertelson, & Kirkley, 1982; Surwit et
al., 1983; Turk & Speers, 1983).
Failure to adhere to the therapeutic regimen may
contribute to metabolic instability (Turk & Speers, 1983).
As previously mentioned, maintenance of metabolic
stability is an important goal of treatment in DM.
Moreover, a number of researchers suggest that failure to
maintain adequate metabolic control may contribute to
development of later complications of the disorder
(Knuiman, Welborn, McCann, Stanton, & Constable, 1986;
Skyler, 1979).

As a result, the potential influence of

both the direct and indirect effects of stress on
metabolic control have generated a great deal of research.
In summary, two major hypotheses exist regarding the
effects of stress on metabolic control in DM: a) direct
effects via an autonomically-mediated arousal mechanism
and b) indirect effects caused by disruption of compliance
to prescribed regimens.

The hypothesized effects of

stress on metabolic control are graphically presented in
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Figure 1.

The following discussion will provide a review

of the stress-arousal and stress-compliance literature.
Stress and Arousal.

In perhaps the most frequently

cited study regarding the effects of stress on metabolic
control, Kemmer et al.

(1986) investigated the effects of

stress associated with mental arithmetic and public
speaking in nine non-diabetic, nine normoglycemic Type I
(i.e., good metabolic control), and nine Type I adults
with induced hyperglycemia (i.e., poor metabolic control).
Moreover, Kemmer et al.

(1986) examined the effects of

stress on the counterregulatory hormones hypothesized to
be causally related to poor metabolic control.

This study

was designed to directly examine arousal effects of
stress-induction on metabolic outcome variables.

Stress

had no effect on measures of blood glucose, plasma
ketones, FFA, GH, or glucagon in patients in either poor
or good metabolic control.

However, significant changes

in NE, E, and cortisol were reported.

These data failed

to support an arousal-mediated stress effect on
metabolism.

The authors conclude metabolic control is not

changed by "sudden, short-lived emotional arousal that may
be produced by the common stressful events of daily life"
(p 1083).
Kemmer et a l . (1986) note several possible reasons
for their negative findings.

First, the increases in

cortisol and catecholamines obtained in the study, while

Disruption
of
C om pliance
B eh aviors
(indirect)
Stress
(direct)

M etabolic
Control

Autonomic
Arousal
(direct)

Figure 1.

Hypothesized Effects of Stress on Metabolic Control,
(O
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27

statistically significant, may have been biologically
insufficient to cause metabolic disruption.

Second, use

of laboratory-induced stressors may not adequately
represent hormonal or metabolic changes accompanying
naturally-occurring stressors.

Conclusions about the

effects of stress on metabolic control are thus limited by
the external validity of the stressors.
In a similar study, Delameter et al.

(1988) reported

significant reductions in GH, cortisol, and free insulin
in 31 adolescent subjects after exposure to either a
cognitive quiz or stressful family interactions.

Glucagon

levels were significantly increased, while glucose, FFA,
E, and NE were unchanged by the stressors.
results of Kemmer et al.

Similar to the

(1986), the stress-arousal

hypothesis was not supported.

However, the results of

this study are limited by use of a relatively brief stress
period (i.e., 10 min) and failure to control statistically
for diurnal variations in GH, cortisol, and free insulin
levels.

In addition, it may be inappropriate to compare

the results of this study with research on adults.

Chase

and Jackson (1981) and Brand, Johnson, and Johnson (1986)
reported age differences in the influence of stress on
metabolic control suggesting caution should be used when
making comparisons between investigations using different
age groups.
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In summary, the results of studies employing a
laboratory stress-induction paradigm are suggestive of a
potential disruptive role for stress on metabolism.
However, these studies (i.e., Delameter et al., 1988;
Kemmer et al., 1986) were unable to support the stressarousal hypothesis.

Unfortunately, methodological

problems may have precluded adequate evaluation of the
arousal hypothesis.
An overriding criticism of the stress-arousal studies
is their lack of relevance to daily life (Goetsch,
Jacobson, 1986).

1989;

Laboratory-induced stressors may differ

significantly from naturally-occurring stressors.
Stressors employed in the laboratory are relatively
circumscribed and short-lived.

In addition, they may have

limited meaning to research participants.

In contrast,

naturally-occurring stressors may be more prolonged or
have greater subjective impact for the individual.
Moreover, multiple naturally-occurring stressors may have
a cumulative impact on the individual sufficient to result
in metabolic disruption.

The lack of generalizability to

daily life represents a major concern regarding
investigations utilizing a stress-induction paradigm.
Stress and Compliance.

In response to the

methodological limitations associated with laboratoryinduced stressors, other investigations have focused on
the influence of stressful life events on metabolic
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stability.

Studies employing a life-events paradigm have

yet to address the stress-arousal hypothesis.

Instead,

these studies have focused on the indirect effects of
stress via disruption of compliance behaviors.
Nonetheless, life-events investigations represent an
improvement over the previously discussed stress-arousal
studies because of their greater external validity and
more accurate representation of the effect of naturallyoccurring events on metabolic stability.

A review of

available literature regarding the stress-corapliance
hypothesis will now be presented.
Using both adolescent and adult IDDM patients,
Schafer, McCaul, and Glasgow (1986) had subjects self
monitor blood glucose testing, diet, and insulin use for
two 1-wk periods (at initial contact and at 6 month
follow-up).

Compliance was assessed using self-monitoring

of blood glucose testing, diet, and insulin injections and
efforts were made to quantify compliance measures.
Research participants also completed the Diabetes Family
Behavior Checklist (a measure of supportive and
nonsupportive family behaviors related to diabetes selfcare) on both occasions.

Results for adults indicated

stressful family interactions were negatively correlated
with compliance with glucose testing, diet, and insulin
use.

Moreover, compliance with blood glucose testing was

significantly associated with HbAl (i.e., glycosylated
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hemoglobin, a relatively long-term measure of metabolic
stability) at 6 month follow-up.

No relation between

stressful family interactions, compliance, and metabolic
control were found for the adolescents included in the
sample suggesting possible age effects in the stresscompliance relation.
Hanson and Pichert (1986) investigated the effects of
daily minor stress on compliance in a group of 39
adolescents at a summer camp for diabetic children.

Using

a stress measure designed specifically for adolescents
with diabetes, these authors reported stress disrupts
dietary and exercise compliance.

The number and intensity

of negative stressors were negatively correlated with the
number of calories consumed, suggesting that as stress
increased, the amount eaten decreased.

Compliance with

diet was positively related to blood glucose levels while
compliance with exercise was inversely related to
metabolic control.

Moreover, Hanson and Pichert (1986)

reported stress had additional effects on blood glucose
independent of its effects via changes in diet and
exercise.
In contrast, several researchers have reported the
effects of stress to be independent of compliance to
treatment regimens.

Using the Hassles Scale, a monthly

measure of minor stress (Kanner et al., 1981), Cox et al.
(1984) investigated the stress-compliance hypothesis in 60

adult: research participants with 1DDH.

Compliance was

assessed by having subjects rate degree of compliance in
each of four areas (i.e., insulin use, diet, blood/urine
glucose testing, and exercise) on a scale from 0 ("not at
all") to 100% ("completely).

With the exception of

insulin use, compliance measures were pooled to form a
global compliance measure.

Results of the study revealed

daily stress was positively associated with blood glucose
control as measured by HbAl, however, self-reported
compliance was not related to either blood glucose control
or stress.

In addition, stress and compliance ratings did

not interact, suggesting the effects of stress on
metabolic control in this study were not moderated by
compliance with diabetic regimen.
Several studies with adolescent samples also have
indicated an independent relation between stress and
compliance (Hanson, Henggeler, & Burghen, 1987a; 1987b).
Hanson et al. (1987a; 1987b) found both stress and
compliance directly influenced metabolic control but were
unrelated to each other.

Although the authors conclude

the link between the direct effects of stress and
metabolic stability is "probably physiological" no test of
the arousal hypothesis was included in this study.
More recently, Halford, Cuddihy, and Mortimer (1990)
conducted a longitudinal investigation of the relations
among stress, compliance, and metabolic control in 15
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adults with IDDM.

Participants monitored blood glucose,

exercise, diet, and insulin use daily for eight weeks.
Using a within-subjects design, stress was found to
predict blood glucose in seven of the 15 subjects.
Similar to the results of the Cox et al.

(1984)

investigation, the effects of stress on metabolic control
were independent of compliance.
Investigations of the stress-compliance hypothesis do
little to resolve the stress-metabolism relation.

Four of

the six studies reviewed noted independence between stress
and compliance effects on metabolic stability.

These

findings contrast with the stress-compliance hypothesis
and suggest stress does not negatively influence behaviors
related to compliance.

The results of these studies,

however, must be tempered by a number of methodological
shortcomings.

Specifically, these shortcomings may be

grouped into three categories, that is, those related to
the assessment of stress, the assessment of compliance,
and the assessment of metabolic control.
First, three studies reviewed did not include an
adequate assessment of stress.

In the Halford et al.

(1990) study, subjects rated stress on a 9 point scale
from "little or no stress" to "extreme stress."

Subjects

were instructed to use the Hassles Scale (Kanner et al.,
1981) as a guide to "what was meant by psychological
stress" (Halford et al., 1990; p 519).

Use of a global
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unstandardized measure of stress may have obscured any
potential stress-compliance relations.

Moreover,

it is

difficult to know whether subject ratings were based on
the frequency of minor life events or their subjective
impact.

Regardless, use of this means to assess stress

introduces a source of error into the investigation.
Similarly, the Hanson and Pichert (1986) study failed to
use a standardized stress measure.

Finally, while the

negative family interactions employed in the Schafer et
al.

(1986) investigation are suggestive of a stressful

environment they almost certainly include other constructs
as well.
Second, four studies used an inadequate assessment of
compliance.

In the investigation by Cox and his

colleagues (1984), assessment of compliance was based on
ratings of subjective degree of compliance.

Global

ratings based on retrospective recall do little to explain
the relation between stress, compliance, and metabolic
control.

Because stress may disrupt performance of

behaviors related to compliance, a more direct assessment
of compliance behaviors would serve a more useful purpose.
In addition, Hanson et al.
measures.

(1987a, 1987b) pooled adherence

Schafer, Glasgow, McCaul, and Dreher (1983)

suggest compliance to one aspect of treatment may be
independent of other components.

Thus, combining
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compliance measures may not adequately portray stress
effects.
Although Halford et al. (1990) examined components of
compliance, this investigation also suffers from problems
associated with compliance measurement.

In the dietary

compliance measure used in the Halford et al. (1990)
investigation, subjects rated dietary compliance on a 5point scale from "mostly poor foods with no good foods" to
"mostly good foods with no poor foods" after being
provided with a list of poor, moderate, and good foods.
Failure to obtain a diet diary may obscure fluctuations in
dietary compliance not apparent with a global daily
rating.
The stress-compliance studies also have
methodological problems associated with assessment of the
dependent measure.

In order for the results of these

studies to be meaningful, accurate reflection of metabolic
stability for the time period under investigation must be
obtained.

Four of six studies used HbAl as the primary

indicator of metabolic stability.

HbAl, while a reliable

and valid measure of metabolic control, reflects blood
glucose control over a 6 to 8 week period.

More proximal

measures of metabolic control would appear to give more
precise information about the stress-compliance relation.
When more proximal measures of metabolic control are
obtained these measures should be accurate representations
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of metabolic control.

In the Halford et al.

(1990)

investigation, subjects self-monitored blood glucose three
times daily.

In question is the means by which subjects

obtained these measures.

According to the authors, some

subjects used glucometers while others used visually read
glucostrips to determine blood glucose levels.
Reflectance glucometers are significantly more accurate
than reading of glucostrips.

Use of two means of

assessing blood glucose may have contributed to the
negative findings in the Halford et al.

(1990) study.

In

addition, no subjects used glucometers equipped with
memory capability.

Ample evidence exists to suggest

individuals with IDDM may significantly under-report blood
glucose levels (e.g., Mazze et al., 1984; GonderFrederick, Julian, Cox, Clarke, & Carter, 1988).

Although

Halford and colleagues indicate memory equipped
glucometers were not available at the time of their study,
failure to further investigate stress-compliance relations
based on potentially erroneous results may be premature.
Summary and Conclusions.

Two principal hypotheses

have been posited regarding the effects of stress on
metabolic stability in IDDM.

First, stress is believed to

have direct effects on metabolic control through a
sympathetically-mediated arousal mechanism.

Via action of

the stress hormones, stress may adversely influence
carbohydrate metabolism leading to metabolic instability.

Previous investigations of the effects of sympathetic
nervous system arousal in IDDM have relied exclusively on
the potential disrupting influence of brief laboratoryinduced stressors.

However, these studies fail to support

an arousal-mediated effect of stress on metabolic outcome
variables (e.g., Kemmer et al., 1986).

Several

investigators have extensively criticized use of
laboratory-induced stressors because they lack relevance
to naturally-occurring stressful events (e.g., Goetsch,
1989).

This methodological concern highlights the

importance of studying stress and its impact in the
natural environment.
A second hypothesis regarding the effects of stress
on metabolic control involves its indirect effects on
compliance with a prescribed treatment regimen.

According

to this hypothesis, behavioral disruption associated with
the occurrence of stressful events may influence the
willingness with which individuals with IDDM adhere to
their diets, perform insulin injections, exercise, or
monitor glucose.

Because compliance with treatment is an

important variable in maintaining metabolic control, the
occurrence of stress may increase risk of developing later
complications of the disease associated with metabolic
instability.
Research addressing the stress-compliance hypothesis
has employed a more ecologically valid means of

determining stress than investigations of the stressarousal hypothesis.

Yet, while some investigators report

an adverse effect of life events stress on compliance with
treatment (e.g., Schafer, HcCaul, & Glasgow, 1986), others
found the effects of stress to be independent of
compliance (e.g., Cox et al., 1984; Hanson et al., 1987a;
1987b).

However, these investigations suffer from

significant methodological problems that may have made
stress-compliance relations difficult to find.
In summary, investigations of the stress-arousal
hypothesis have employed a means of assessing stress with
limited generalizability to naturally-occurring stressors.
Few investigations have been conducted in this area, and
they have failed to support a sympathetically-mediated
arousal effect on metabolic control.

To date, there have

been no investigations of the direct effects of naturallyoccurring stressors on metabolic control via arousal
mechanisms.

Similarly, the results of investigations of

the stress-compliance hypothesis have done little to
explain stress effects on metabolic stability.

THE CURRENT STUDY
This study was designed to investigate the two
primary hypotheses regarding the effects of stress on
metabolic control in adults with IDDM.

That is, both the

direct effects proposed to result from a sympatheticallymediated arousal process and indirect effects resulting
from disruption of compliance to treatment regimen were
examined.

Although both hypotheses are generally accepted

in the DM literature, both have been indadequately
explored.
Delineating the relative contributions of an arousalmediated process or a process of disruption of compliance
behaviors has potential impact for treatment of
individuals with IDDM.

Tailoring treatment to the cause

of the disorder is an important variable in treatment
outcome.

As such, determining the cause of metabolic

instability resulting from stress would suggest that those
who respond to stress with a predominant autonomic
response may best be helped with a stress management
approach to treatment while those who respond to stress by
changes in compliance behavior might be more appropriately
addressed through behavioral management.
The relation between minor life events, compliance
behaviors, sympathetic arousal, and blood glucose in adult
patients with IDDM was examined.

Specifically, this study

explored whether naturally-occurring minor stressful
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events have disruptive effects on metabolic control
through: a) an arousal mechanism, b) disruption of the
individual's adherence to a prescribed treatment regimen,
c) a combination of arousal and disruption of compliance,
or d) a third unspecified mechanism.

The present study

addressed methodological shortcomings of previous
investigations by simultaneously: a) employing a
psychometrically sound and ecologically valid means of
assessing stress, b) quantifying compliance measures,

and

c) using a valid, accurate, and proximal means of
assessing metabolic control.
Research Questions Addressed by the Study
1.

Do naturally-occurring minor stressors influence

metabolic control by disrupting compliance with diet,
exercise and/or insulin use?

Although much of the

previous stress-compliance research has been equivocal,

it

is expected that the quantified compliance measures
employed in the current study will indicate the stresscompliance relation does influence metabolic control.
However, stress may have a relatively greater effect on
some aspects of the treatment regimen than others.

No

specific hypotheses are made regarding the effects of
stress on metabolic control via the separate components of
compliance (i.e., diet, exercise, and insulin use)
assessed in this study.

2.

Do naturally-occurring minor stressors influence

metabolic control via a sympathetically-mediated pathway?
Based on available knowledge about the effects of minor
stressors on cortisol and the effects of cortisol on
metabolic control, minor stress is expected to exhibit a
disruptive influence on metabolic stability via changes
in urinary free cortisol.
3.

Do naturally-occurring minor stressors have

effects on metabolic stability independent of stresscompliance and stress-arousal relations?

While the

stress-compliance and stress-arousal hypotheses are the
primary means by which stress is proposed to have its
effects on metabolic control, there is no extant reason to
believe stress may not have effects on metabolic stability
independent of these relations.

However, the stress-

compliance and stress-arousal hypotheses are expected to
account for the majority of the variance in predictions of
metabolic control based on available research.

METHOD
Subjects
Forty-five adult volunteers with IDDM were studied.
Subjects were patients at the West Virginia University
Health Sciences Center or the University of Texas Medical
Branch at Galveston.

Subjects were recruited in one of

two ways: 1) by referral from their primary care physician
or 2) via newspaper advertisements.

None were pregnant

during the course of the study and none were taking
medications known to influence the human stress response
(e.g., beta blockers, calcium channel blockers, steroids,
or anxiolytics).

All subjects had been diagnosed with

IDDM for a minimum of one year (mean duration = 15.5
years, SD = 8.99).
Two subjects failed to exhibit correspondence between
glucometer memory readings and self-reports of blood
glucose on their daily diaries.

This information brought

into question the reliability of other self-report data
for these subjects and consequently these subjects were
dropped from the subject pool.

Three additional subjects

were eliminated because the age at diagnosis of their
disease (i.e., 44, 45, and 50 years) suggested Type II
diabetes according to criteria proposed by Welborn,
Garcia-Webb, Bonser, McCann, and Constable (1983).
final sample for the investigation consisted of 4 0
participants.
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The
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Demographic data was collected on all subjects (see
Appendix A).

Mean age for the study participants was 33.5

years with a standard deviation of 10.35, while mean age
at diagnosis of XDDM was 17.8 years (SD = 9.17).

The

subjects in this study were primarily white (87.5%) and
had at least a partial college education (77.5%).

Forty-

seven and one-half per cent were married, while the
remainder were either separated/divorced (17.5%) or never
married (35%).

The majority were employed (62.5%) and had

an average income of between $10,001 to $15,000 annually.
Complete demographic data for the sample are presented in
Table 1.
Informed consent was obtained from all subjects prior
to involvement in the study.

Copies of informed consent

from both West Virginia University Health Sciences Center
and the University of Texas Medical Branch are presented
in Appendix B.

Research subjects were compensated for

their time at the rate of $5.00 per day for each day of
monitoring completed ($15.00 total).

One subject refused

monetary incentive.
Measures
Daily Stress Inventory.

The DSI (Brantley & Jones,

1989) is a 58 item self-report inventory of daily
stressful events or minor stressors.

Respondents indicate

which of 58 stressors occurred during the previous 24
hours and then rate endorsed items on their perceived
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Table 1.

Demographic Data for the Sample.

Variable

Frequency

Percent

Male
Female

21
19

52.5
47.5

Race

White
Black
Other

35
2
3

87.5
5.0
7.5

Marital status

Married
Divorced/Separated
Never married

19
7
14

47.5
17.5
35.0

Educational
Level

Graduate/Professional
College graduate
Partial college
High school graduate
Junior high (7-9 yrs)

8
7
16
8
1

20.0
17.5
40.0
20.0
2.5

Employment
Status

Full time
Part-time
Student
Unemployed

20
5
10
5

50.0
12.5
25.0
12.5

Income

less than $5000
$5001 - 7500
$7501 - 10,000
$10,001 - 15,000
$15,001 - 25,000
$25,001 - 50,000
$50,001 - 100,000

13
0
1
6
8
9
3

32 .5
0.0
2.5
15.0
20.0
22.5
7.5

Gender

impact using a Likert scale from 1 ("occurred but was not
stressful") to 7 ("caused me to panic").
scores can be derived from the DSI:

Three primary

1) the Event Score

represents the number of stressful events reported as
occurring during the previous 24 hour period, 2) the
Impact Score is the sum of the perceived impact ratings,
and 3) the I/E Ratio is the average impact rating for the
previous 24 hour period.

Only the Event and Impact Scores

were used in the current study.

Validity studies of the

scale indicate good convergent (Brantley et al., 1987) and
construct (Brantley, Cocke, Jones, & Goreczny, 1988b;
Goreczny, Brantley, Buss, & Waters, 1988) validity.
Moreover, data exist to suggest the scale is sensitive to
fluctuations in urine measures of norepinephrine
metabolites and cortisol (Brantley et al., 1988a)
indicating the scale has good convergent validity with
biochemical indicators of stress.

Normative data for the

scale exist for both normal and medical populations.
Compliance Measures.

Measures of compliance with

treatment regimen were divided into three components;
compliance with diet, exercise, and insulin use.
Compliance with prescribed diet was assessed by
having subjects monitor all food intake daily for three
days.

Subjects were provided with monitoring forms on

which to record food intake (see Appendix C ) .

Data

obtained from food intake monitoring was then converted to
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the number of exchanges in each of the six food groups
(i.e., milk, vegetable, fruit, bread/starch, meat, and
fat) using the Minipress Dietrak software program (NSquared Computing, 1989) for personal computers.

The

number of exchanges eaten in each food group was then
subtracted from

the

number of exchangesprescribed in each

group

to obtain the

total number of exchange deviations

(both

additions and

deletions) for thatday.

total

number of exchange deviations wassummed and divided

Finally, the

by the total number of exchanges prescribed yielding the
Diet Deviation Score.

Dietary compliance was, therefore,

expressed as a ratio of exchange deviations to the total
number of exchanges prescribed.
For example, if the individual added two fat
exchanges and deleted one bread exchange relative to their
prescribed diet, a total of three exchange deviations
would be counted for that day.

Moreover, if the

individual's prescribed diet called for 12 planned
exchanges per day, the total dietary deviation score for
that day would be .25 or 3/12.

Previous research suggests

this method of quantifying dietary compliance in
individuals with IDDM is sensitive to metabolic outcome
measures (Christensen, Terry, Wyatt, Pichert, & Lorenz,
1983) .
A test of normality of the distribution of diet
deviation scores (i.e., a Shapiro-Wilk W statistic)

46
indicated these scores were normally distributed (ShapiroWilk W= .95, fi = .20).
To assess compliance with medication, subjects
recorded the time, type, and amount of insulin used at
each injection (see Appendix D).

Similar to compliance

with diet, compliance with insulin use was expressed as
the proportion of insulin deviations from prescribed
insulin regimen.
defined as:

Deviations in insulin use are

a) changes in timing of insulin of more than

one hour or omission of an injection (one deviation); and
b) inappropriate changes in amount of insulin (one
deviation).

Appropriate changes in insulin timing or

amount to accommodate meals, exercise, hypo- or
hyperglycemia were not counted as insulin deviations.

The

sum of each day's insulin deviations was divided by the
number of insulin injections per day times two (i.e., the
number of potential sources of error for that injection:
timing/omission or amount) to obtain the daily insulin
deviation score.
A Shapiro-Wilk w statistic (Shapiro & Wilk, 1965)
indicated the distribution of raw insulin deviation scores
was not normal (Shapiro-Wilk W = .92, p = .01).

Cohen and

Cohen (1983) suggest proportional data be transformed to
"linearize" the data under these circumstances.

An

arcsine transformation was, therefore, performed on these
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data.

In all data analyses, Insulin deviation scores were

expressed as arcsine transformed proportions.
Exercise compliance was determined by having subjects
monitor the frequency, duration, and type of exercise
performed on Exercise Monitoring Logs (see Appendix E ) .
Exercise compliance was quantified by multiplying the
frequency of actual exercise performed during the three
day monitoring period by 2.3333 to obtain an actual weekly
frequency score (i.e., 2.3333 days times 3 days of the
study equals weekly frequency).

Actual exercise frequency

was converted to a weekly exercise frequency score for
ease of analysis because most physicians instruct patients
to exercise a set number of times per week (as opposed to
a set number of times every three days).

Actual exercise

frequency was operationalized as the number of times an
individual performed discrete exercises (e.g., workouts,
aerobics).

That is, walking in the mall, housework, or

activities associated with job responsibilities were not
counted as exercise.

The absolute value of the difference

between the actual weekly frequency score and the
prescribed frequency score served as the Exercise
Compliance Score for this study.

Ten subjects reported no

physician recommendations regarding exercise and two
subjects had missing data for this measure.

Data analyses

for exercise compliance were, therefore, based on 28
subjects.

Data for Exercise Compliance Scores were found
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to be normally distributed (Shapiro-Wilk W = .93, p =
.08).
To assess compliance with prescribed treatment, each
participant completed a Prescribed Treatment Log (see
Appendix F).

Values from the Prescribed Treatment Log

were used to determine the denominators in each equation
involving compliance with diet and medication and
prescribed frequency of exercise.
Urinary Free Cortisol.

Urinary free cortisol levels

were determined by Flourescence Polarization Immunoassay
(FPIA) using the TDX Systems (Abbott Laboratories; North
Chicago, Illinois).

All assays were conducted within four

weeks of collection and urine samples were kept frozen at
-20

C until the assays were performed.

Urine samples

were returned to room temperature and thoroughly mixed
prior to testing.

Samples containing large amounts of

particulate matter were centrifuged before assaying.
To control for differences in volume of urine
collected, creatinine levels also were assayed for each
urine sample.

Creatinine level was determined by

Radiative Energy Attenuation (REA) using the TDX Systems
(Abbott Laboratories; North Chicago, Illinois).

Use of

REA technology for creatinine assay is reported to be
extremely accurate when compared with reference assays
(Mean = .99; Abbott Laboratories; North Chicago,
Illinois).

All laboratory tests were conducted by trained
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laboratory technicians in the Psychopharmacology
Laboratory in the Department of Behavioral Medicine and
Psychiatry at the West Virginia University Health Sciences
Center.

Laboratory technicians were blind to the

hypotheses of the research.
The distribution of cortisol:creatinine raw data
indicated a non-normal distribution (Shapiro-Wilk W = .87,
E < .0001).

An arcsine transformation was, therefore,

performed on these data as suggested by Cohen and Cohen
(1983).

In all data analyses, urinary free cortisol

levels were expressed as an arcsine transformed ratio of
cortisol:creatinine.
Blood Glucose.

Blood glucose levels were determined

four times daily through use of the One Touch Blood
Glucose Monitoring System (Lifescan, Milpitas,
California).

The One Touch System, a second-generation

blood glucose monitoring system, determines blood glucose
levels when a drop of blood is placed on a glucose oxidase
regeant strip.

Unlike many other blood glucose monitoring

devices, the One Touch System does not require timing or
removal of blood from the regeant strip and consequently
reduces potential sources of user error (JovanovicPeterson, Peterson, Dudley, Kilo, & Ellis, 1988).

In

addition, research comparing blood glucose levels
determined by the One Touch System with those of a glucose
analyzer indicate excellent precision and accuracy

50

(Jovanovic-Peterson, Peterson, Dudley, Kilo, & Ellis,
1988).
Use of the One Touch requires individuals to lance
the side of a finger with a lancet pen to obtain a droplet
of blood.

Blood is then placed on a regeant strip and

entered in the One Touch System.

Blood glucose levels are

digitally displayed to the user in mg/dL and as many as
250 previous results can be held in memory.

For the

present study, subjects were informed the One Touch System
had memory capability and they were asked to record their
daily blood glucose levels on a monitoring sheet (see
Appendix D ) .

Blood glucose levels for data analysis were

expressed as daily means.
Procedure
After an initial screening interview, the purpose of
the study and potential risks were explained to all
subjects.

The primary investigator was available to

answer questions from subjects when obtaining informed
consent.
Eligible participants were first trained to self
monitor blood glucose.

All subjects were trained to use

the One Touch System according to Lifescan protocol.

In

addition, each subject was provided written instructions
on use of the One Touch.

Research participants were

considered adequately trained when two consecutive trials
were achieved with blood glucose values within five
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percent of each other (mean across subjects = 3.8%).

Each

participant was provided with a One Touch System including
sufficient lancets, alcohol prep pads, and regeant strips
to complete four blood glucose readings daily for three
days.

Subjects were instructed to record blood glucose

before breakfast, lunch, dinner, and retiring each day and
enter the obtained values in their monitoring logs.
Each subject completed the DSI daily for four days at
approximately the same time before retiring for the
evening.

Data from DSI recording on the first day was

discarded because research has indicated the DSI is
reactive on the first day of monitoring (Brantley et al.,
1988b).

In addition, Brantley et al. (1988b) found

differences between DSI scores on weekdays and weekends,
therefore, all self-monitoring was conducted on weekdays
to control for this potential source of variance.
Beginning on Day Two of DSI recording, subjects also
completed monitoring forms for compliance assessment daily
for three days.

Participants were instructed to record

foods consumed, insulin injections, and exercise on their
self-monitoring forms.

Subjects were instructed to

continue to eat, exercise, and use their insulin just as
they did before involvement in the study in an effort to
decrease reactivity.
Finally, participants were asked to collect all urine
voided between the hours of 2 p.m. and 4 p.m.

(to control
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for diurnal variations in cortisol output) in labeled
urine collection containers provided to each subject.
Collection of urine for cortisol assay began on Day Two of
DSI recording concurrent with self-monitoring of
compliance and continued for three consecutive days.
Urine samples were then frozen by the subjects at the end
of the each day and returned to the principal investigator
at the end of the three day monitoring period.
Following the three days of urine collection, DSI
recording, and compliance self-monitoring, subjects
completed a Prescribed Treatment Log, were debriefed and
released.

RESULTS
Descriptive statistics
Preliminary descriptive statistics of the measures
employed in the study (i.e., DSI Event and Impact scores,
insulin deviation scores, diet deviation scores, exercise
compliance scores, cortisol, and blood glucose) were
conducted.

The mean DSI Event Score was 15.74, placing

the research participants of this study at the 83rd
percentile (T=60) in terms of frequency of minor stressful
events compared to other medical patients.

Similar

results were obtained with the DSI Impact Score (mean =
39.47, 83rd percentile, T=60).

The mean blood glucose

reading was 181.51 mg/dL for this sample.

Table 2

contains means and standard deviations for other measures
used in the study.
To determine if research participants from Texas and
West Virginia differed substantially on any of the
demographic,

independent, or dependent variables, a series

of T-tests was conducted.

Results of these analyses

indicated no difference between subjects from Texas and
West Virginia on any study variable.

These data are

presented in Table 3.
Correlations
Correlations were used to examine the interrelations
between variables.

An 8 X 7 correlation matrix of

demographic measures with the primary predictor and
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Table 2. Descriptive Statistics for Primary Study
Variables.

Variable

Mean

Standard Deviation

DSI Impact Score

39.47

24.88

DSI Event Score

15.74

11.46

181.51

54.99

Diet Deviation Score

1.05

.35

Insulin Deviation Score3

0.34

0.32

Exercise Compliance Score

2.60

1.48

Cortisol:Creatinine
ratio3

0.12

.06

Blood Glucose (mg/dL)

Note. a Arcsine transformed variable.
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Table 3.

T-tests for Differences Between States on
Demographic and Primary Measures of Study.

t

Variable

Age
Age at diagnosis

.76

ns

-1.49

ns

.22

ns

to
to

ns

Marital status

-0.55

ns

1.64

ns

Blood glucose

-0.76

ns

DSI Impact Score

-0.44

ns

DSI Event Score

-1.72

ns

1.18

ns

Diet deviation score

-0.03

ns

Insulin deviation score3

-0.31

ns

Income

Cortisol:creatinine
ratio3

H

•

•
0
1

Exercise compliance score

H

Employment status

1

Education

Note.

E

a Arcsine transformed variables.

ns

outcome measures was generated to examine possible
intercorrelations between demographic and
predictor/outcome variables.

The eight demographic

variables included in this correlation matrix were: age,
ethnic group, gender, marital status, education,
employment status, income level, and age at diagnosis.
The seven predictor/outcome variables were mean DSI Impact
and Event scores, mean diet deviation score, mean insulin
deviation score, mean exercise compliance score, mean
cortisol:creatinine ratio, and blood glucose.

An alpha

level of .01 was used to indicate statistical significance
to control for experimenter-wise error.
presented in Table 4.

The results are

Race demonstrated a significant

negative correlation with blood glucose (r = -.45, p <
.01).

This suggests that the nonwhite research

participants in this study had lower blood glucose levels
than the white participants had.

No other correlations

between demographic and predictor or outcome variables
were significant.
A 7 (predictor/outcome variables) X 7
(predictor/outcome variables) correlation matrix also was
generated, with statistical significance again set at p =
.01.

These results are presented in Table 5.

The

correlation between DSI Impact and DSI Event Scores was
significant (r = .74, p < .01).

The significant

correlation between DSI Impact and Event Scores suggests

Table 4.

Correlation Matrix of Demographic and Predictor/Predicted Variables.

Age at
Diagnosis

Age

Race

Gender

Marital
Status

Education

DSI Impact Score

-0.37

-0.11

0.16

0.30

0.18

0.15

-0.36

-0.27

DSI Event score

-0.25

0.05

0.12

0.25

0.08

0.06

-0.25

-0.13

Diet Deviation
score

-0.05

-0.11

-0.16

-0.02

0.04

-0.20

0.22

0.16

0.15

-0.27

-0.17

-0.08

-0.02

-0.15

0.11

0.07

Exercise Compliance
Score

-0.07

0.08

-0.15

0.19

-0.14

0.13

-0.26

0.06

Cortisol:Creatinine
Ratio

-0.05

-0.02

-0.02

-0.17

0.17

0.05

-0.11

-0.03

Blood Glucose

-0.04

-0.45** -0.12

-0.13

-0.05

0.12

0.07

-0.06

VARIABLE

Insulin Deviation
Score

Employment

Income

Note.**g < .001

(ji
'O

Table 5.

Correlation Matrix of Predictor/Predicted Variables (n).

VARIABLE

DSI impact
Score

DSI
Impact
Score

DSI
Event
Score

Diet
Deviation
Score

Insulin
Exercise
Deviation Compliance
Score
Score

Blood
Glucose

1.00

DSI Event
Score

.74**
(40)

1.00

Diet Deviation
Score

.01
(26)

-.27
(26)

1.00

-.10
(40)

-.14
(40)

-.04
(26)

1.00

Exercise Compliance
Score

.19
(28)

.12
(28)

-.17
(22)

-.12
(28)

1.00

Cortisol:Creatinine
Ratio

.39**
(40)

.08
(40)

.38
(26)

-.14
(40)

-.15
(28)

Blood Glucose

.20
(40)

.16
(40)

.21
(26)

Insulin Deviation
Score

Cortisol:
Creatinine
Ratio

.43**
(40)

-.0004
(28)

1.00
.11
(40)

1.00

Note.**p < .001

ui
03
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that either variable may be used to accurately represent
an individual's experience of daily minor stress.
However, Brantley and Jones (1989) suggest DSI Impact
Scores may be the best indicator of an individual's
experience of stress because the score takes into account
personal appraisal of events.

Therefore, only the DSI

Impact Scores were used to quantify minor stress in the
subsequent analyses (i.e., simple and multiple
regressions).
A significant positive relation between DSI Impact
Score and cortisol also was demonstrated (r = .39, p <
.01).

However, neither DSI Impact nor DSI Event Scores

were significantly correlated with any other
predictor/outcome variables.

Finally,

intercorrelation

was noted between blood glucose and the insulin deviation
score (r = .43, p < .01).
No relation between compliance measures was found.
Lack of significant correlations between the three
compliance measures (i.e., diet, exercise, and insulin
use)

indicated the need for separate regression analyses

for each of these predictor variables in subsequent
analyses.

All other correlations were nonsignificant.

Simple Regressions
Whereas zero-order correlations indicate strength of
association between two variables, simple regression
allows determination of the amount of variance in a given
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variable that can be predicted when the value of a second
variable is known.

Four separate regressions were,

therefore, performed using DSI Impact Score as the
regressor to investigate the degree to which diet
compliance, insulin compliance, exercise compliance, or
cortisol levels can be predicted when daily minor stress
is known.
Table 6.

The results of these analyses are shown in
The regression of DSI Impact Score on diet

deviation score was nonsignificant, r2 (l,24) = .000, as
was the regression of DSI Impact on insulin deviation,
r2 (l,38) = .010, and exercise compliance, r2 (l,26) = .035.
However, a significant relation between DSI Impact and
cortisol, r2 (l,38) = .151, p < .01, was found.
A second series of simple regressions were conducted
to determine if blood glucose (i.e., metabolic control)
can be predicted when compliance and cortisol levels are
known.

In the first of these analyses, the insulin

deviation score was the regressor.

The results of this

analysis were significant, r2 (l,38) = .184, p < .01.
Simple regressions employing cortisol, r2 (l,38) = .013,
diet deviation score, r2 (l,24) = .046, and exercise
compliance, r2 (l,26) = .000, as regressor variables were
nonsignificant.

The results of these analyses are

presented in Table 7.
A score for exercise duration also was derived (i.e.,
the absolute value of the difference between actual

Table 6.

Results of Simple Regressions with DSI Impact:
Score as Regressor Variable.

Predicted variable

df

x2

Diet deviation

(1,24)

.000

ns

Insulin deviation

(1,38)

.010

ns

Exercise compliance

(1,26)

.035

ns

Cortisol

(1,38)

.151

.01**

Note.

** £ < .01

p
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Table 7.

Results of Simple Regressions vith Blood
Glucose as Predicted Variable.

Predictor variable

Diet deviation score

df

r2

E

(1,24)

.046

ns

Insulin deviation score (1,38)

.184

**

Exercise compliance

(1,26)

.000

ns

Cortisol:creatinine
ratio

(1,38)

.013

ns

Note.

**

e

< *01
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exercise duration and prescribed exercise duration) to
determine if exercise duration successfully predicted
blood glucose.

However, exercise duration also failed to

exhibit a significant relation with blood glucose,
r2 (1,26) = .002.
Finally, the direct (i.e., unmediated) relation
between daily minor stress and metabolic control was
investigated via a simple regression with DSI Impact Score
as the regressor variable and blood glucose as the
predicted variable.

The results of this analysis were

nonsignificant, r2 (l,38) = .040.
Multiple Regressions
Multiple regression analyses permit determination of
the amount of variance accounted for in a predicted
variable while controlling for the effects of the
regressor variables.

Specifically, hierarchical multiple

regression was selected because these procedures permit
entry of the regressor variables in a pre-specified order
based on theory or the purpose of the research (Cohen &
Cohen, 1984).

Specifying order of entry permits removal

of variance associated with spurious or confounding
variables.

By entering variables early, and thereby

removing the variance associated with them, a relatively
pure test of a given variable's predictive ability can be
conducted.
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To directly test the effects of an interaction
between minor stress score and insulin compliance on blood
gluose (while controlling for the main effects of minor
stress and insulin compliance), variables were entered
into a hierarchical regression in the following order:
DSI Impact Score, Insulin Deviation Score, with the DSI
Impact by Insulin deviation interaction entered last.

The

full model was significant, F(3,36) = 4.09, p - .01, and
accounted for 25% of the variance.

However, the

interaction of stress and insulin compliance was
nonsignificant.

Only the insulin deviation score was

significant, nr2 = .215, p < .05.

These results are

presented in Table 8.
Similarly, a second multiple regression was performed
using minor stress, urinary free cortisol and the DSI
Impact Score by cortisol interaction to explore the
relation between stress, cortisol and metabolic control.
Variables were entered into the equation in the following
order:

DSI Impact Score, cortisol, and DSI Impact X

cortisol interaction.
predicted variable.

Blood glucose served as the
This order of entry allows for a

direct test of the effects of a minor stress by cortisol
interaction in the prediction of blood glucose.

As

expected based on the results of the simple regressions
(i.e., no significant relation between cortisol and blood
glucose), the full model for this regression was
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Table 8.

Regression of Daily Minor Stressors. Insulin
Compliance, and Their Interaction on Blood
Glucose.

Source

df

£

Model

3

4.09

Error

36

Total

B2

.25

£

.1D1

39

Variable

Partial r2

£

DSI Impact Score

.051

ns

Insulin Deviation Score

.215

.04

Interaction

.013

ns
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nonsignificant, F(3,36) = .52, and none of the regressor
variables successfully predicted blood glucose.

The

results of this regression are presented in Table 9.
A multiple regression to explore the interaction of
stress and diet compliance also was conducted.

Variable

entry in the regression equation was as follows:

DSI

Impact Score, Diet deviation score and the DSI Impact by
diet interaction, with blood glucose as the predicted
variable.

As presented in Table 10, the full model was

nonsignificant, F(3,22) = .46, and no regressor variable
predicted blood gluocse.
An identical analysis using exercise compliance and
the DSI Impact X exercise compliance interaction also
yielded nonsignificant results (see Table 11).

To

determine if the influence of daily stress on blood
glucose was mediated by exercise duration, a hierarchical
multiple regression was performed using (in order of
entry) the exercise duration score and the DSI Impact X
exercise duration interaction as regressor variables.
However, neither exercise duration or a DSI Impact X
exercise duration interaction successfully predicted blood
glucose, F(3,24) = .69.
Hierarchical multiple regression also was performed
to examine the direct effects of insulin compliance on
metabolic control controlling for the effects of stress.
Order of entry for the predictor variables for this

67
Table 9.

Regression of Daily Minor Stressors. Cortisol,
and Their Interaction on Blood Glucose.

Source

Model
Error
Total

df

F

3

.520

.04

E

ns

36
39

Variable

Partial r2

DSI Impact Score
Cortisol:creatinine ratio
Interaction

B2

.040
.001
.000

e

ns
ns
ns
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Table 10.

Regression of Daily Minor Stressors. Diet
Compliance, and Their Interaction on Blood
Glucose.

Source

df

Z

Model

3

.462

Error

22

Total

R2

.06

E

ns

25

Variable

Partial r2

£

DSI Impact Score

.000

ns

Diet deviation score

.046

ns

Interaction

.013

ns
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Table 11.

Regression of Daily Minor Stressors. Exercise
Compliance, and Their Interaction on Blood
Glucose.

Source

df

Model

3

Error

24

Total

F

.942

B2

E

.10

ns

27

Variable

Partial r2

£

DSI Impact Score

.000

ns

Exercise compliance score

.0006

ns

Interaction

.092

ns

analysis were DSI Impact Score and insulin deviation
score.

Blood glucose served as the predicted variable.

The DSI Impact Score was entered first followed by the
insulin deviation score.

Because the goal of this

analysis was to examine the unique variance associated
with insulin compliance on metabolic control, the results
are presented in terms of semipartial correlation
coefficients as suggested by Cohen and Cohen (1983).
Semipartial correlation coefficients represent the
correlation between the predicted variable
independent variable in question after

and the

the effects of the

shared variance of the two (or more) independent variables
have been removed (Edwards, 1984).

The full model was

significant, F(2, 37) = 5.98, p < .01, and accounted for
24% of the variance.

Insulin compliance was found to

successfully predict blood glucose independent of stress
and account for 20%

of the variance in metabolic control,

sr2 = .204, p < .01 (see Table 12).
Similarly, to determine if diet compliance influenced
blood glucose independently of stress, a hierarchical
multiple regression with DSI Impact score entered first
followed by the Diet Deviation Score was performed.
glucose was the predicted variable.
nonsignificant, F(2,23) = .56.

Blood

The full model was

Diet compliance was not

found to influence blood glucose independently of stress
(sr2 = .045).

Cortisol (F(2,37) = .80, sr2 = .001) and

71
Table 12.

Direct Effects of Insulin Compliance on Blood
Glucose Controlling for the Effects of Daily
Minor Stressors.

Source

df

Model

3

Error

37

Total

Z

5.98

B2

.24

U

.006

39

Variable

sr2

E

DSI Impact Score

.040

ns

Insulin deviation score

.204

.003
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exercise compliance (F(2,25) = .18, sr2 = .0005) also had
no direct effects on blood glucose when the variance
associated with stress was statistically removed.
A final hierarchical regression employed blood
glucose as the predicted variable and insulin compliance,
cortisol, and DSI Impact Score as predictor variables.
The DSI Impact Score was the final variable entered into
the equation to determine if minor stress had direct
effects on metabolic control not accounted for by a
stress-arousal or stress-compliance relation.

Diet and

exercise compliance were not included in this analysis
because neither of these components of compliance had been
shown in previous analyses to influence blood glucose.
The cost to statistical power of including these
variables, did not, therefore, appear justified.

The full

model was significant (F(3,36) = 4.04) and accounted for
25% of the variance in blood glucose.

However, as shown

in Table 13, the only significant predictor of blood
glucose was the Insulin deviation score (sr2 = .201, p <

.0 1 ).
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Table 13.

Regression of Insulin Compliance. Cortisol, and
Daily Minor Stressors on Blood Glucose.

Source

Model
Error
Total

df

3

F

R2

4.04

.25

p

.01

36
39

Variable

sr2

Model
R2

p

Cortisol:creatinine

.013

.01

ns

Insulin deviation score

.201

.21

.003

DSI Impact score

.038

.25

ns

DISCUSSION
Minor stress did not influence short-term metabolic
control either independently or via a stress-compliance
or stress-arousal mechanism in this sample of individuals
with IDDM.

Consistent with previous research (i.e.,

Brantley et al., 1988a), stress was related to cortisol
activity, but neither the direct effects of cortisol nor a
cortisol by stress interaction successfully predicted
metabolic control.

Moreover, stress was unrelated to diet

or exercise compliance and no relation between diet or
exercise compliance and metabolic control was found.

Only

insulin compliance was found to influence metabolic
control, although the effects of insulin compliance were
independent of a stress-compliance relation.
Stress has been repeatedly portrayed in the
literature as influencing metabolic control in Type I
diabetes, yet the results of the current study suggest no
relation between stress and metabolic control for this
sample.

The inability to find a stress-blood glucose

relation is consistent with some previous research (e.g.,
Edwards & Yates, 1985; Kemmer et al., 1986).

However,

other groups have reported significant relations between
metabolic disruption and stress (e.g., Cox et al.,
1984; Hanson & Pichert, 1986; Hanson et al., 1987a,
1987b).
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Several potential reasons for the negative findings
of the current study exist.

First, several of the studies

reporting a stress-blood glucose relation used adolescent
samples (i.e., Hanson et al., 1987a, 1987b; Hanson &
Pichert, 1986).

Although poorly understood, adolescents'

metabolic response to stress may be different from that of
adults (Brand et al., 1986; Chase & Jackson, 1981).
Schafer et al.

(1986) found a differential effect of age

regarding the stress-glucose relation in a mixed sample of
adults and adolescents.

The lack of comparability between

stress' influence on blood glucose in adults and
adolescents suggests it may be inappropriate to compare
the results of the current study to investigations
employing adolescent or mixed samples.
Second, the current study improved over past
investigations by improving assessment of both the
independent and dependent measures (i.e., stress and blood
glucose).

Use of the DSI to assess daily minor stress

provided a reliable, valid, and standardized means of
assessing naturally-occurring stress.

Many previous

investigations relied on unstandardized stress measures
(e.g., Halford et al., 1990; Hanson & Pichert, 1986)
making comparisons with the current study problematic.
It should be noted, however, that the results of the
current study are consistent with the results of the
carefully controlled laboratory stress study by Kemmer et
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al.

(1986).

Perhaps, when stress is validly assessed (as

in the current investigation and the Kemmer et al. study)
no reliable relation between stress and blood glucose
exists.
Moreover, the present study used an extremely
accurate and proximal measure of metabolic control, that
is, multiple daily reflectance glucometer readings as
opposed to the more distal HbAl.

Much of previous

research relied exclusively on HbAl to assess metabolic
control (e.g., Cox et al., 1984).

Improved accuracy in

the assessment of the variables under investigation
increases the probability that any existing stress-blood
glucose relation would be found.

Methodological

shortcomings of the past research may have indicated the
presence of stress-metabolic relations where none actually
existed.

Conversely, daily minor stress may have a

cumulative long-term effect on blood glucose (i.e., as
measured by HbAl), but not influence short-term glycemic
control as assessed by reflectance glucometers.
A third possible explanation for the negative
findings of the current study involves the experimental
design.

The study employed a cross-sectional approach

that may have obscured any significant relations between
stress and metabolic control by collapsing data across
subjects.

That is, some individuals in the study may have

experienced metabolic disruption in response to stress,
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but there may have an insufficient number of these
individuals to override the effects of those who
experienced no metabolic effects.

Carter, Gonder-

Frederick, Cox, Clarke, and Scott (1985) found
idiosyncratic metabolic responses to stress withinsubjects that were stable across time suggesting
individual differences in stress-responsivity.

Similarly,

Halford et al. (1990) used a within-subjects design and
found stress influenced blood glucose in only seven of 15
subjects.
These data suggest only certain individuals with IDDM
may respond to stress via metabolic disruption while
others may be relatively metabolically insensitive to the
influence of stress.

Within-subjects designs require

observation of the study variables over a sufficiently
long period of time to provide ample variance in the
variables of interest.

The three days of self-monitoring

used in the current study, however, did not allow for
examination of within-subject differences.

It may be that

with longer periods of investigation using within-subjects
designs stress-glucose relations could be found.
Finally, much of the previous literature on the
direct unmediated effects of stress on blood glucose has
included both Type I and Type II (noninsulin-dependent;
NIDDM) patients (see Goetsch, 1989 for a review).

Stress

may disrupt metabolic control in Type II patients while
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having little or no impact on IDDM.
notion, Goetsch et al.

In support of this

(1990) found a significant relation

between daily minor stress and metabolic control in Type
II patients while controlling for the influence of diet
and exercise.
Moreover, research investigating the effects of
relaxation training (which would presumably attenuate the
influence of stress) on metabolic control suggests that
IDDM and NIDDM patients may be differentially affected.
Several studies have reported a positive influence of
relaxation training in Type II patients (Surwit &
Feinglos,

1988; Lammers, Naliboff, & Straatmeyer, 1984)

but not Type I (Bradley, Moses, Gamsu, Knight, & Ward,
1985; Landis et al., 1985; Feinglos, Hastedt, & Surwit,
1987).

Surwit and Feinglos (1988) conclude that stress-

related arousal of the sympathetic nervous system may be
more important in the pathophysiology and metabolic
disruption of Type II than Type I patients.

While

individuals with IDDM may perceive stress to be an
important factor in metabolic control (Cox et al., 1984),
this may not actually be the case.
The present study was designed to investigate how
stress influenced short-term metabolic control, that is,
by disrupting compliance with treatment or through an
autonomically-mediated mechanism via cortisol activity.
While the negative results of an unmediated stress-glucose
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relation make the stress-arousal and stress-compliance
issues something of a moot point, several additional
findings of the study warrant comment.
Stress and Arousal
The study represents the first investigation of the
arousal hypothesis using naturally-occurring daily minor
stress.

Previous research (i.e., Delameter et al., 1988;

Kemmer et al., 1986) examining the influence of laboratory
stress has been unable to support an arousal-mediated
relation between stress and metabolic control.

The

results of the current study are consistent with the
findings of this literature.

The methodological

improvements of the current research (i.e., use of a more
externally valid means of assessing stress and controlling
for diurnal variations in cortisol secretion) lend
additional creedence to this body of literature.

At least

in terms of relatively brief stress, influences on
metabolic control may not be secondary to an arousalmediated mechanism.

This finding, however, does not rule

out the possibility of potential long-term stress
influences on glycemic control.
In addition, the negative results of the current
study are supported by replication of the findings of
Brantley et al.

(1988a) involving the influence of daily

minor stress on cortisol.

Had the present study failed to

find the expected positive relation between stress and
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cortisol, the negative findings of the stress-arousal
hypothesis on metabolic control may have been more easily
challenged.

Failure to find a stress-arousal influence on

metabolic control supports previous research and suggests
an arousal-mediated influence of minor stress on metabolic
control may not be tenable.
While the results of this study are consistent with
the previous literature on the stress-arousal relation,
several possible explanations for the negative findings
remain.

Like the Kemmer et al.

(1986) study, increases in

cortisol activity may have been "biologically
insufficient" to disrupt metabolic control.

Although

stress was predictive of cortisol in this study, the
increases in cortisol may have been inadequate to reach
the biological thresholds required to result in metabolic
instability.

It is possible that daily minor stressors,

like laboratory stressors, do not have sufficient
biological impact to cause autonomic activity adequate for
metabolic disruption.
Second, cortisol alone may not accurately represent
the activity of the autonomic nervous system.

Assessment

of a more global autonomic response including
catecholamines and GH may more accurately reflect
autonomic arousal.

While Kemmer et al.

(1986) did assess

a number of other indicators of autonomic arousal in
addition to cortisol, they failed to demonstrate a

relation between these biological indicators of stress and
blood glucose control.

However, Kemmer et al.'s results

with other autonomic indicators have not been replicated
with naturally-occurring stressors and were not assessed
in the current study.

Further research using an

externally valid means of assessing stress and a broader
spectrum assessment of autonomic activity will be required
to address this question.
Finally,

it may be that the sample of individuals

with IDDM in the study are not representative of the
general population with IDDM.

Participants in the study

were in relatively good control of their blood glucose and
free from any long-term complications of the disease.
Perhaps the effects of an arousal-mediated mechanism of
stress becomes more apparent with increasing severity of
disease and the presence of complications.
this possibility is Kemmer et al.'s (1986)

In support of
finding that

cortisol levels were higher in hyperglycemic IDDM patients
compared to normoglycemic patients.

Individuals with

poorer metabolic control (i.e., more severe disease) may,
therefore, be more susceptible to the effects of stress.
It should be noted, however, that length of illness was
not found to be related to either cortisol or stress in
the present study suggesting no influence of this measure
of disease severity.
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Compliance
The preliminary correlations conducted indicated no
relation between diet, exercise, and insulin compliance.
This finding is consistent with previous research
suggesting independence of the separate components of
compliance (Schafer et al., 1983).

Nonetheless, many

investigations of the influence of compliance on metabolic
control have used a composite or pooled compliance measure
(e.g., Hanson et al., 1987a, 1987b) combining several
aspects of compliance with treatment.

The preliminary

correlations of the present study suggest combining
separate aspects of compliance may be inappropriate.
While the independence of the separate components of
compliance found in this study must be interpreted
cautiously because of the relatively small sample size,
the finding may have important implications for future
research.

To more accurately portray the relation between

compliance and metabolic control, future research would
benefit from examination of independent compliance
behaviors rather than an overall compliance construct.
This would allow determination of the specific areas in
which an individual may be experiencing difficulties and
allow for development of interventions targeted at these
problem areas.
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Stress and Compliance
Daily minor stress was unrelated to diet, exercise,
or insulin compliance in this study.

In addition, no

effect of the interaction between the separate components
of compliance and stress was found suggesting independence
of stress and compliance effects.

These findings are

consistent with the majority of past research (e.g., Cox
et al., 1984; Halford et al., 1990) indicating
independence of stress and compliance influences on
metabolic control.

However, the methodological

improvements of the current study (i.e., quantified
compliance assessment and use of a standardized means of
assessing naturally-occurring stress) supports this body
of literature and suggests stress-compliance relations may
not influence short-term metabolic control in IDDM.
Insulin compliance was related to metabolic control
in this sample.

The relation between insulin compliance

and blood glucose was in the expected direction; that is,
the less compliant individuals were with taking their
insulin (i.e., the higher the insulin deviation score),
the poorer their metabolic control.

Insulin compliance

was found to predict 20% of the variance in metabolic
control independent of the perceived impact of daily minor
stress.

These findings are consistent with required

treatment for IDDM and make intuitive sense.
is not taken, blood glucose levels rise.

If insulin

84
Perhaps more surprising are the negative findings
regarding the influence of diet compliance on metabolic
control.

Diet compliance accounted for only 5% of the

variance in metabolic control in this study, but
interpretation of these results must be made cautiously.
The data analyses regarding diet compliance are not based
on the total sample.

As was discussed in the Methods

section, the number of dietary exchanges prescribed was
used as the denominator in the diet deviation ratio.
Derivation of the number of exchanges prescribed was based
on the total number of calories in a given individual's
American Diabetes Association (ADA) prescribed diet
(Powers, 1987).

However, only 26 of the subjects in the

study were able to indicate the number of calories
prescribed in their ADA diets.

The fourteen remaining

subjects reported no knowledge of the number or type of
calories they were meant to eat and therefore could not be
included in the data analysis.
This finding suggests significant lack of knowledge
regarding dietary recommendations for treatment of IDDM in
at least a portion of the subjects in this study.

In

addition, it brings into guestion how one can reasonably
expect individuals with IDDM to comply with dietary
treatment recommendations if they do not have knowledge or
understanding of these recommendations.

That is, how can

compliance with diet be accurately assessed if the people
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with the disorder do not know what is expected of them?
While this finding is epiphenomenon to the specific
objectives of the current study, it represents an
important result.

Do the negative results of the diet

compliance data reflect an actual lack of relation between
dietary adherence and metabolic control or are the results
confounded by those subjects who indicated limited
knowledge of their dietary treatment recommendations?
Similarly, does the lack of reported knowledge about the
number of calories prescribed in an ADA diet indicate a
special case of noncompliance?
The means by which the data were analyzed in the
current study does not allow for resolution of these
questions.

However, these results do suggest directions

for both future research and clinical endeavors.

Future

research appears needed to determine if those individuals
who report a lack of knowledge about their dietary
treatment recommendations differ in other aspects of
compliance behaviors (or more generally) from those
individuals with IDDM who do report knowledge of this area
of their treatment.

Research to this end may help resolve

some of the questions surrounding the compliance-blood
glucose issues and would improve the accuracy with which
the stress-compliance hypothesis can be investigated.
A second point to be gained from this finding
suggests future research involving quantification of diet
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compliance should seek to determine those individuals who
are knowledgeable about their diet versus those who are
not a priori.

These results also have clinical

implications and suggest that more frequent sessions with
a nutritionist to review and revise dietary needs may be
useful to improve both general IDDM care and dietary
compliance.
Summary and Implications for Future Research
This study was conducted to examine the relation
between daily minor stress, compliance behaviors, cortisol
activity and short-term blood glucose control in IDDM.
Improvements in methodology over previous research were
made by simultaneously: a) employing a psychometrically
sound and ecologically valid means of assessing stress; b)
quantifying compliance measures; and c) using a valid,
accurate, and proximal means of assessing metabolic
control.
The results of the study indicated daily minor stress
did not influence short-term metabolic control, either
through a direct unmediated influence, via disruption of
compliance with treatment, or an autonomically-mediated
mechanism.

Insulin compliance was found to negatively

influence blood glucose control, however, diet and
exercise compliance and cortisol activity had no impact on
the dependent measure.

Daily minor stress was found to

predict cortisol activity.
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The results of the current study suggest several
lines for further research.

First, within-subjects

studies examining the role of naturally-occurring stress
on metabolic control appear needed.

These studies should

be done in conjunction with efforts to more accurately
quantify compliance measures as was done in the current
study.

Within-subjects designs would allow for

determination of those individuals who may be most
susceptible to the influence of stress on metabolic
control.

The ability to identify stress-reactive prone

individuals may allow for improved treatment tailored to
the specific needs of the patient.
Second, studies comparing samples of Type I and Type
II diabetes appear to be needed to address potential
differences in stress-responsivity in these two groups of
patients.

Available research suggests these studies may

be best conducted using a longitudinal design allowing for
examination of individual difference influences on
outcome.

In addition, future research should employ

assessment of a wider range of indicators of autonomic
activity including catecholamines and GH.
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Subject Number:
Race/Ethnic Group:

Age: ________
Sex:

M

F
Married
Widowed
Divorced/Separated
Never married

Marital Status:

Graduate/Professional
College graduation
Partial college
High school graduation
Partial high school (10-11 years)
Junior high school (7-9 years)
Less than 7 years of school

Education:

Employment:

Full time
Full time homemaker
Part time
Student
_ Unemployed

Annual Income:

Less than $5,000
$7,500 - 10,000
$10,001 - 15,000
$15,001 - 25,000
$25,001 - 50,000
$50,001 - 100,000
$1 00 ,000 +

Date Diabetes was first diagnosed:
Age at Diagnosis:
Height:

Weight:

White
Black
Other

APPENDIX B
Informed Consent
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UTMB
I have been asked to participate as a subject in the
research project titled The relation between stress and
insulin-dependent diabetes mellitus under the direction of
Diane Garrett, M.S. The purpose of the study is to
examine the effects of daily stress on blood glucose in
persons with Type I diabetes.
It is the goal of this
study to further knowledge about the effects of stress on
individuals with diabetes.
I understand the experimenter will show me how to use a
digital glucometer, how to lance my finger for a drop of
blood, and how to record the reading on a monitoring form.
I will be given forms to record my blood glucose, diet,
exercise, insulin use, and daily stress.
I will be asked
to record these readings for three (3) consecutive days.
I also understand I will be asked to collect a urine
sample in the containers provided to me for the same three
(3) day period.
I understand I will be asked to freeze
each urine sample at the end of the day and return the
samples to the experimenter at the end of the study. The
experimenter may phone me periodically to insure I am not
having difficulty with any of the recording procedures.
Following the three (3) day monitoring period, I
understand I will then be asked to return my forms,
glucometer, and urine samples to the experimenter.
I also
will be asked to complete a questionnaire at that time.
Before I leave I will be paid and the results of the study
explained to me.
I understand there are no alternate procedures to this
project other than to decline participation.
I also
understand there are no costs or special fees for
participating.
I understand that I will not directly benefit from my
participation in the research project. However, my
involvement in this project will serve to further
knowledge about the effects of stress on individuals with
diabetes.
The potential risks associated with the study are minimal.
When I return to the laboratory for the completion of the
study, I understand I will receive monetary compensation
of $5.00 for each day of home monitoring I completed if I
complete all three days of monitoring.
I also understand that any information collected in this
study will not identify me personally.
I understand that
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I will be assigned a number at the onset of my involvement
in the study and that this number will be used for
identification purposes.
It has been explained to me that
every effort will be made to insure my confidentiality by
using an assigned number on all questionnaires and
monitoring forms.
In signing this consent form, I state that I have read and
understand the description of the monitoring forms and
questionnaire as well as the following statements.
I
understand I will be given a copy of the consent form.
1.

I understand that informed consent is required of all
persons in this project.

2.

The principal and alternate procedures, including the
experimental procedures in this project have been
identified and explained to me in a language that I
can understand.

3.

The risks and discomforts from the procedures have
been explained to me.

4.

The expected benefits from the procedures have been
explained to me.

5.

An offer has been made to answer any questions I may
have about these procedures.
If I have any questions,
before, during, or after the study, I may contact Ms.
Diane Garrett at (409) 772-6730.

6.

I have been told that I may refuse to participate or
stop my participation in this project without
prejudice and without jeopardizing my medical care at
UTMB. All new findings during the course of the
research which may influence my desire to continue or
not to continue to participate in this study will be
provided to me as such information becomes available.

7.

I have been told that the University of Texas Medical
Branch like virtually all other universities in the
United States, does not have a mechanism for
compensation of the injured research subject.
Therefore, I understand I cannot look to any such
mechanism to receive financial remuneration for any
such injuries resulting in my participation in this
project.
If physical injury occurs as a direct result
of this research, emergency treatment which is
available to the general public will be available to
me. Neither UTMB or Diane Garrett, M.S. can assume
financial responsibilities or liability for the
expense of such treatment.
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8.

I understand that if I have any questions about my
rights as a patient participating in this study or a
research-related injury, I may contact Dr. E. Ray
Stinson, Director of the Office of Sponsored ProgramsAcademic at (409) 772-2482.

9.

I understand that I have a right to privacy and all
information that is obtained in connection with this
study and that can be identified with me will remain
confidential as far as possible within state and
federal law. However, information gained from this
study and that can be identified with me may be
released to no one other than the investigator and my
physician.
The results of this study may be published
in scientific journals without identifying me by name.

I voluntarily agree to participate as a subject in the
above named project.

Date

Signature of Subject

Signature of Witness
Using language that is understandable and appropriate, I
have discussed this project and the items listed above
with the subject and/or his/her authorized representative.

Date

Signature of Project Director

104
West Virginia
The purpose of this research is to examine the
effects of daily stress on blood glucose in persons with
Type I diabetes.
It is the goal of this study to further
knowledge about the effects of stress on individuals with
diabetes.
I understand the experimenter will show me how to use
a digital glucometer, how to lance my finger for a drop of
blood, and how to record the reading on a monitoring form.
I will be given forms to record my blood glucose, diet,
exercise, insulin use, and daily stress. I will be asked
to record these readings for three (3) consecutive days.
I also understand I will be asked to collect a urine
sample in the containers provided to me for the same three
(3) day period.
I understand I will be asked to freeze
each urine sample at the end of the day and return the
samples to the experimenter at the end of the study. The
experimenter will phone me periodically to insure I am not
having difficulty with any of the recording procedures.
Following the three (3) day monitoring period, I
understand I will then be asked to return my forms,
glucometer, and urine samples to the experimenter.
I also
will be asked to complete a questionnaire at that time.
Before I leave I will be paid and the results of the study
explained to me.
I understand that any information about me obtained
as a result of my participation in this research will be
kept as confidential as legally possible.
I understand I
will be identified by n u m b e r only. However, I also
understand that my research records, like hospital
records, can be subpoenaed by court order or may be
inspected by federal regulatory authorities.
To the best of my knowledge I am not suffering from
any impairment or disease that might interfere with this
project. When I return to the laboratory for the
completion of the study, I will receive a monetary
compensation of $5.00 for each day of home monitoring I
completed if I complete all three days of monitoring.
There are no direct benefits to me other than the monetary
compensation. Although there are minimal risks associated
with my participation in this study, I understand some
risks may be unforeseeable. Should injury occur as a
result of this research, voluntary compensation is not
provided. There are no costs or special fees for
participating.
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In signing this consent form, I state that I have
read and understand the description of the monitoring and
questionnaires.
Any questions I have had have been
answered to my satisfaction.
I understand if I have any
questions about my rights as a research participant I can
contact the Institutional Review Board for the Protection
of Human Subjects at (304) 293-7073.
I enter into this research willingly as a volunteer
and may withdraw at any time without fear of retribution.
Refusal to participate involves no retribution or penalty
or loss of benefit to which I am entitled.
I will be
given a copy of the consent form.
If I have any further
questions or concerns I may contact the investigator.

Subject's Signature

Date

Investigator's S ignature

Witness
Diane Garrett, M.S.

293-2411

APPENDIX C
Food Diary
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FOOD DIARY
DAY #: _1__

DATE: ____________

Please write down everything you eat or drink from the
time you get up until you go to bed. Include drinks of
all kinds. Specify the AMOUNT, HOW IT WAS PREPARED, AND
ANYTHING THAT IS ADDED such as butter, margarine, fat,
oil, salad dressing, sugar, syrup, etc.

TIME

FOOD DESCRIPTION

AMOUNT

APPENDIX D
Insulin and Blood Glucose Log
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BLOOD GLUCOSE LOG
DAY

Time

Before
Breakfast

DATE: __

Before
Lunch

Before
Evenina Meal

Before
Bedtime

Blood
Glucose
Level
Reading

LOG FOR INSULIN USE

Time
(indicate
actual time)

Type of Insulin

Amount

A.M.
Dose
P.M.
Dose
Other
Other
Please list any other medications and the amount taken
today below:
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APPENDIX E
Exercise Log
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EXERCISE LOG
DAY #: _1__

Time of Day

Type of Exercise

EXAMPLE:
10 a.m.

Jogging

2 D.m.

Housework

Pedometer Reading:

DATE:

Duration of Exercise
15 min.
45 min.

APPENDIX F
Prescribed Treatment Log
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Prescribed Treatment Log
Below are listed a brief series of questions
regarding treatment recommendations made for your care by
your physician.
Please indicate to the best of your
knowledge what your physician asked your to do in each of
the three areas below:
EXERCISE
1.
My physician recommended I exercise.
2.
How frequently did your physician suggest you
exercise?
______ Weekly
______ Twice per week
______ Three times per week
______ More than 3 times per week
3.
How long did your physician suggest you exercise
during each exercise period?
______
Less than 10 minutes
______
1 0 - 1 9 minutes
______
2 0 minutes
______ more than 20 minutes
4. My physician DID NOT recommend I exercise as part
of my prescribed treatment.
INSULIN USE
Please indicate amount, type, and timing of insulin
injections prescribed for you.
TYPE_______________ AMOUNT______________________ TIME_______

DIETARY RECOMMENDATIONS
Please indicate the dietary recommendations prescribed for
you.
__________ calorie ADA diet
__________ other, please explain:
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